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Abstract
Non-fasting TAG – postprandial lipaemia (PPL) – are to a higher degree associated with cardiovascular risk compared with fasting TAG.
Dietary protein, especially whey proteins (WP), may lower PPL. We hypothesised that a WP pre-meal (17·6 g protein) consumed 15 v. 30min
before a fat-rich meal reduces the PPL response in subjects with the metabolic syndrome (MetS) and that a WP pre-meal has more potent
effects than casein and gluten pre-meals. A total of sixteen subjects with the MetS completed an acute, randomised, crossover trial. WP pre-
meals were consumed 15 and 30min, and casein and gluten 15min before a fat-rich meal. Blood samples were drawn 360min postprandially
to determine metabolite and hormone responses, S-paracetamol (for assessment of gastric emptying) and amino acids. Insulin and glucagon
responses were affected by both timing and protein type (for all P< 0·01), with significantly higher concentrations for WP given at –15min
than WP at –30min and higher responses compared with gluten for the first 30min after pre-meal consumption (for all P< 0·05). The PPL
responses changed neither by timing nor by protein type. Glucose-dependent insulinotropic peptide but not glucagon-like peptide 1
responses differed between the three protein types. S-paracetamol concentration was higher for WP (–30min) than for WP (–15min) 15min
after the main meal (P= 0·028), and higher for casein and gluten than for WP at time point 30min (for all P< 0·05). In conclusion, the PPL
response was not changed by ingestion of a 17·6 g protein pre-meal, whereas both timing and protein quality affected hormone secretion
(insulin and glucagon).
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The metabolic syndrome (MetS) is a cluster of risk factors for
development of atherosclerotic CVD and type 2 diabetes (T2D)
that encompass abdominal obesity, insulin resistance, hyper-
tension and dyslipidaemia(1). Thus, hypertriacylglycerolaemia is
a characteristic feature of the MetS. Recent studies have
demonstrated that CVD is more strongly associated with
increased levels of TAG in the non-fasting state, that is, post-
prandial lipaemia (PPL), compared with the fasting state(2,3).
Diet is one of the most important modifiers of PPL. A century
ago, Staub(4) and Traugott(5) noted that glucose tolerance
improved after the second of two consecutive glucose chal-
lenges, the so-called Staub–Traugott effect. In continuation of
this finding, it turned out that consumption of whey proteins
(WP) from milk before ingestion of carbohydrate diets was
associated with enhanced insulin responses to these diets. Thus,
WP pre-meals significantly reduce glycaemic responses(6–9),
delay gastric emptying(8,10) and stimulate glucagon-like peptide 1
(GLP-1) secretion(10); and WP is more effective in this respect
compared with other proteins(11–13). WP pre-meals give rise to a
pronounced increase in the plasma concentrations of lysine,
threonine and branched-chain amino acids (BCAA) (leucine,
isoleucine and valine)(11). These amino acids (AA) and BCAA in
particular mimic the insulinotropic properties of WP(14). In
subjects with and without T2D, WP as part of a fat-rich meal
also reduces PPL compared with casein, cod and gluten
proteins(15,16). In addition, we recently demonstrated the dif-
ference between 0 and 20 g WP consumed as a pre-meal before
a fat-rich main meal(17). Even though a pre-meal of 20 g of WP
did not influence PPL in this study(17), we cannot exclude that
pre-meals with other protein sources may influence PPL. We
Abbreviations: AA, amino acid; BCAA, branched-chain amino acid; E%, energy percentage; GIP, glucose-dependent insulinotropic peptide; GLP-1, glucagon-
like peptide 1; iAUC, incremental AUC; PPL, postprandial lipaemia; WP, whey protein.
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therefore hypothesised that different protein pre-meals differ-
entially affect PPL after ingestion of a fat-rich meal in subjects
with the MetS. We aimed to compare the impact of a small dose
(17·6 g pure protein) of WP with that of casein and gluten
protein. We also wanted to investigate whether the time span
between the pre-meal and the main meal influences PPL
responses. We hypothesised that a WP pre-meal would elicit a
lower PPL response if consumed 15min before a fat-rich meal
than if consumed 30min before a meal.
Methods
Participants
A total of twenty-eight subjects were recruited from August 2014
to January 2015 through local newspapers. All interested sub-
jects were screened for the MetS as defined by the International
Diabetes Federation(1). We included women and men
above 18 years with the MetS and having had a stable weight for
at least 3 months. Exclusion criteria are abnormal TAG
(>5mmol/l) or blood pressure (160/100mmHg); clinically sig-
nificant CVD; renal, liver or endocrine disease; diabetes; alcohol
or drug abuse; current treatment with steroids; pregnancy and
lactation; or a significant psychiatric medical history. Regular
medication was accepted if the dose had been stable for a
minimum of 4 weeks and could be continued throughout
the study period. A total of eleven subjects were taking
antihypertensive therapy and nine were being treated with
cholesterol-lowering medication. A total of six women and ten
men completed the study. All subjects provided their written
informed consent. The protocol was approved by the Central
Denmark Region Committees on Health Research Ethics (ID:
1-10-72-189-14), and the trial was performed in accordance with
the Declaration of Helsinki. The study was registered with
ClinicalTrials.gov (ID: NCT02228252).
Design
The present study was an acute, randomised, crossover study
with four arms. The four test days were separated by washout
periods of approximately 1 week where subjects consumed
their habitual diets. The subjects were randomly allocated to the
four test meals according to a randomisation list made on www.
randomization.com. On a full day before each test day, the
subjects consumed a ready-prepared standard diet (20% energy
(E%) as protein, 54 E% as carbohydrates and 26 E% as fat).
Women had a diet containing of 7000 kJ and men 9000 kJ.
Before the test day, subjects were asked to avoid alcohol,
demanding physical activity and painkillers containing
paracetamol.
After a 12 h overnight fast, the participants arrived to our
clinic (Aarhus University Hospital, Aarhus, Denmark). A
catheter was inserted in a cubital vein for collecting fasting
blood samples, and urine sample and anthropometric mea-
surements were obtained. Subsequently, the participants con-
sumed a pre-meal, waited 15 or 30min and ingested a fat-rich
meal within 15min. During the entire test period, the partici-
pants were allowed to drink 200ml tap water.
Test meals
Participants consumed pre-meals with three different protein
types (WP, casein and gluten proteins) 15min before the fat-
rich meal. The pre-meals contained equivalent amounts of pure
protein (17·6 g), which corresponds to 20 g WP isolate. As the
fourth intervention, a WP pre-meal was given 30min before the
fat meal. The pre-meals were not blinded. Blood samples were
drawn at the following time points: –15 (only when pre-meal
was consumed 30min before the main meal), –10 and 0min.
The nutrient composition and the relative AA compositions of
the protein powders are listed in Table 1. We used a WP isolate
(Lacprodan DI-9224 Instant; Arla Foods Ingredients Group P/S).
The casein powder was a sodium caseinate spray dried from
pure milk protein (Miprodan® 30; Arla Foods amba). A total
amount of 17·6 g pure protein (20 g WP and 19 g casein) was
blended with 200ml tap water and 30 g frozen strawberry. WP
and casein were served drinkable. The gluten protein powder
(wheat gluten; Reppe Lantmännen) was insoluble in cold water.
Therefore, 21 g of total gluten protein was blended with 50ml
water and 30 g strawberry. The mixture was eatable with a
teaspoon and served with 150ml water.
A standardised, fat-rich breakfast meal was served at time
point 0min. The meal consisted of white bread, rye bread,
butter, cheese, salami, bacon, egg, milk and decaffeinated
coffee. The energy composition was 17 E% as protein, 15 E% as
carbohydrates and 68 E% as fat. The fat composition was 47·8%
from SFA, 27·8% from MUFA and 6·5% from PUFA. The total
Table 1. Nutrient composition and the relative amino acid composition of
the three protein powders
Protein type
Whey Casein Gluten
Nutrient composition*
Amount of protein powder (g) 20 19 21
Total protein (g) 17·6 17·6 17·6
Total fat (g) 0·3 0·1 0·4
Total lactose (g) <0·02 <0·06 –
Total energy (kJ) 310·6 305·0 314·0
Amino acid composition adjusted to WP (100)
(relative (g))†
Ala 100 45 59
Asp (Asn) 100 108 193
Cys 100 0 83
Glu (Gln) 100 90 174
Gly 100 52 98
His 100 99 98
Ile 100 49 45
Leu 100 58 55
Met 100 84 66
Phe 100 106 147
Pro 100 764 908
Ser 100 77 135
Thr 100 80 79
Trp 100 92 91
Tyr 100 108 87
Val 100 68 62
WP, whey protein.
* Data on WP and casein are provided from Arla Foods Ingredients Group P/S, and
data on gluten are provided from Reppe Lantmännen.
† We were not able to measure lysine and cystine in the protein samples due to
irregular shapes of GC and MS peaks.
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energy content was 3 900 kJ. The participants received 1·5 g
paracetamol (3× 500mg tablets of Pinex®; Actavis) and 100ml
water together with the meal. Blood samples were subse-
quently drawn postprandially after the main meal at 15, 30, 60,
90, 120, 180, 240 and 360min.
Blood analysis
All samples were obtained using EDTA except for glucagon
(tubes contained EDTA and aprotonin) and samples for serum
preparation. The samples were placed on ice immediately after
sampling and separated by centrifugation at 2000 g for 15min at
4°C. Serum samples were separated from full blood after cen-
trifugation at 2000g for 15min at room temperature. All samples
were frozen at –20°C and stored at –80°C. Plasma insulin was
analysed using an ELISA kit (code: K6219; Dako Denmark A/S).
Glucagon was measured using a radioimmunoassay kit specific
for pancreatic glucagon with glucagon antibody and
125I-glucagon (catalogue no. GL-32K; Millipore). The COBAS
c111 system (Roche Diagnostics GmbH) was used for mea-
surement of TAG, NEFA, glucose and paracetamol in serum.
The system used an enzymatic colorimetric method; commer-
cial kits were used for analysis of TAG (ref. no. 04657594190;
Roche Diagnostics GmbH) and NEFA (ref. no. 434-91795 and
436-91995; Wako Chemicals GmbH). Plasma glucose was
analysed using an enzymatic reference method with hexo-
kinase (ref. no. 04657527190; Roche Diagnostics GmbH).
S-paracetamol was quantified using a colorimetric method (ref.
no. 03255379 190; Roche Diagnostics GmbH). One subject did
not receive paracetamol due to hypersensitivity to paracetamol.
GLP-1 and glucose-dependent insulinotropic peptide (GIP)
concentrations were measured with a radioimmunoassay. Total
GLP-1 (i.e. the sum of intact GLP-1 and its metabolite GLP-1
9–36 amide) was measured using an antiserum specific for
C-terminal in GLP-1 (no. 89390)(18). Likewise, an antiserum
specific for C-terminal in GIP (code no. 867) was used for total
GIP. Free AA from plasma were analysed using an in-solution-
chloroformate derivatisation after pH adjustment to 5–6 using
100 µl of 7 M NaOH, followed by chloroform extraction as per-
formed by Qiu et al.(19) with minor changes. The obtained ethyl
esters were separated on a HP-5ms capillary column coated
with polyimide (60m× 0·25mm internal diameter, 0·25 µm film
thickness (Agilent Technologies)) and quantified on a 7890A
GC system coupled with a 5975c inert mass selective detector
(MSD) quadrupole mass spectrometer (Agilent Technologies).
Protein powders were hydrolysed and subsequently analysed in
the same way as plasma samples.
Statistical analysis and calculations
The statistical power calculation was based on our primary
effect parameter, viz. TAG incremental AUC (iAUC). The
number of participants needed to obtain a statistical power of
80% at a level of P< 0·05 (α= 0·05, 1–β= 0·8) was 16. The
anticipated dropout level was set at 20%. Descriptive statistics
are presented as means with 95% CI, unless otherwise stated.
Statistical analyses were performed in STATA/IC 14.2 (Stata-
Corp), and graphics were made in GraphPad Prism 7.0
(GraphPad Software Inc.). We calculated iAUC (TAG, insulin,
glucagon, glucose, GLP-1, GIP, S-paracetamol and AA) using
the trapezoid model. Total AUC (tAUC) was used for NEFA.
Student’s t test was applied to compare the difference in iAUC
and tAUC for biochemical parameters regarding timing. One-
way ANOVA was used for comparison of differences in iAUC
and tAUC for biochemical parameters and AA regarding protein
types. We applied ANOVA for repeated measurements to
examine the effect of the intervention (pre-meal) and time on
postprandial responses. Subject and day were used as random
variables, order as covariates, and lipid-lowering drugs as sys-
tematic variables. Statistically significant differences at indivi-
dual time points were analysed by estimates for linear
combinations and indicated in figures by letters. P< 0·05 was
considered statistically significant. Validation was performed by
inspecting quantile–quantile plots, histograms and Bland–
Altman plots.
Results
Table 2 presents the participants’ baseline characteristics.
A total of twenty-eight subjects were screened, twenty were
randomised and sixteen completed the study. Screening was
unsuccessful in eight subjects. In all, four withdrew after ran-
domisation for personal reasons. Table 3 shows the effect of
timing and protein type during the postprandial period, and
Table 4 shows the means of iAUC and tAUC for the biochemical
parameters.
TAG and NEFA
The concentration of TAG in the four groups peaked after
240min. None of the participants in the four groups had
returned to fasting TAG values 360min after ingestion of the fat-
rich main meal. Fig. 1(a) shows that the postprandial TAG
response was independent of the type of protein pre-meal
(P= 0·95) and its timing (P= 0·87). TAG iAUC were also similar.
We observed similar postprandial NEFA suppressions in all
four groups; suppression reached a minimum at 60min and
returned to fasting levels at 360min (Fig. 1(b)). Timing
(P= 0·22) or pre-meal type (P= 0·79) had no effect.
Table 2. Baseline characteristics of the sixteen subjects with the meta-
bolic syndrome
(Mean values and 95% confidence intervals)
Total group
Characteristic Mean 95% CI
Sex, females/males 6/10
Age (years) 65·4 62·0, 68·8
Weight (kg) 88·7 79·9, 97·6
BMI (kg/m2) 29·6 27·5, 31·7
Waist:hip ratio 0·968 0·932, 1·00
Systolic blood pressure (mmHg) 136·6 129·1, 144·2
Diastolic blood pressure (mmHg) 81·8 77·2, 86·5
Glucose (mmol/l) 6·02 5·73, 6·30
TAG (mmol/l) 1·56 1·10, 2·02
HDL-cholesterol (mmol/l) 1·48 1·25, 1·70
314 A. Bjørnshave et al.
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Table 3. Effect of timing and protein type: postprandial concentration of biochemical parameters after consumption of a whey protein (WP) pre-meal 15 or 30min before a fat-rich main meal, or a pre-meal of
casein or gluten protein in subjects with the metabolic syndrome (n 16)
(Medians, mean values and 95% confidence intervals)
Intervention (pre-meal)
WP (–15min) WP (–30min) Casein Gluten
Parameter (unit) Time (min) Median 95% CI Median 95% CI Median 95% CI Median 95% CI Timing (P)* Protein type (P)†
TAG (mmol/l) Fasting (–15/–30min) 1·60 1·46, 1·75 1·52 1·38, 1·66 1·57 1·43, 1·72 1·54 1·40, 1·68 0·8668 0·9541
240 2·91 2·65, 3·18 2·84 2·58, 3·10 2·85 2·60, 3·11 2·77 2·52, 3·02
360 2·45 2·23, 2·68 2·37 2·15, 2·58 2·36 2·14, 2·57 2·48 2·26, 2·71
NEFA (mmol/l) Fasting (–15/–30min) 0·51 0·45, 0·57 0·50 0·44, 0·55 0·46 0·41, 0·51 0·47 0·41, 0·52 0·2164 0·7891
60 0·16 0·14, 0·17 0·15 0·13, 0·16 0·15 0·14, 0·17 0·18 0·16, 0·20
360 0·57 0·50, 0·63 0·55 0·49, 0·61 0·52 0·46, 0·58 0·53 0·47, 0·59
Insulin (pmol/l) Fasting (–15/–30min) 79·0 65·9, 92·1 81·8 68·2, 95·4 83·1 69·3, 96·9 59·8 49·8, 69·8 0·0001 0·0062
15 408·8a 340·8, 476·8 349·9 291·6, 408·1 374·1a 311·8, 436·3 253·3b 211·1, 295·5
120 214·8 179·1, 250·5 199·4 166·2, 232·6 186·5 155·5, 217·5 171·0 142·5, 199·4
Glucagon (pg/ml) Fasting (–15/–30min) 78·3 72·4, 84·1 81·5 75·4, 87·6 77·8 71·9, 83·6 75·6 69·9, 81·3 <0·0001 <0·0001
15 151·9a 140·5, 163·3 145·3 134·3, 156·2 146·8a 135·7, 157·8 115·0b 106·3, 123·6
120 111·8 103·4, 120·2 113·6 105·0, 122·1 117·7 108·8, 126·5 107·3 99·2, 115·4
Glucose (mmol/l) Fasting (–15/–30min) 0·3990 0·9333
Mean 5·73 5·74 5·61 5·64
95% CI 5·49, 5·98 5·49, 5·99 5·37, 5·87 5·39, 5·89
30
Mean 5·73 5·69 5·88 6·02
95% CI 5·49, 5·98 5·44, 5·94 5·63, 6·13 5·77, 6·27
120
Mean 5·41 5·58 5·39 5·41
95% CI 5·17, 5·66 5·33, 5·83 5·14, 5·64 5·16, 5·66
GLP-1 (pmol/l) Fasting (–15/–30min) 13·6 12·4, 14·8 12·5 11·4, 13·6 13·1 11·9, 14·2 13·2 12·0, 14·4 0·4826 0·6188
120 33·6 30·7, 36·6 30·7 28·0, 33·5 30·6 27·8, 33·3 33·1 30·1, 36·0
360 15·2 13·8, 16·5 16·2 14·7, 17·6 17·5 16·0, 19·1 16·9 15·4, 18·4
GIP (pmol/l) Fasting (–15/–30min) 8·4 6·8, 9·9 8·3 6·8, 9·9 8·6 7·0, 10·2 6·9 5·7, 8·2 0·0789 0·0103
120 82·4 67·0, 97·7 73·3 59·6, 87·0 79·1 64·4, 93·8 65·3 53·1, 77·5
360 31·5 25·3, 37·4 32·8 26·7, 38·9 42·3 34·4, 50·2 32·0 26·0, 37·9
Paracetamol (µmol/l) 30 0·0013 0·3986
Mean 60·6 94·6 93·4 102·3
95% CI 44·3, 76·9 78·3, 110·9 77·0, 109·7 86·0, 118·6
120
Mean 86·0 72·0 84·6 77·3
95% CI 69·7, 102·3 55·7, 88·3 68·2, 100·9 61·0, 93·6
GLP-1, glucagon-like polypeptide 1; GIP, gastric inhibitory polypeptide.
a,b Values within a row with unlike superscript letters were significantly different (P<0·05).
* ANOVA for repeated measurements. The hypothesis was to test whether the response curves for the two interventions (WP (–15min) and WP (–30min)) during the postprandial period were parallel.
† ANOVA for repeated measurements. The hypothesis was to test whether the response curves for the three interventions (WP (–15min), casein or gluten) during the postprandial period were parallel.
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Table 4. Incremental AUC (iAUC) and total AUC (tAUC) of biochemical parameters and amino acid after consumption of a whey protein (WP) pre-meal 15 or 30min before a fat-rich main meal, or a pre-meal
of casein or gluten protein in subjects with the metabolic syndrome (n 16)
(Mean values, medians and 95% confidence intervals)
Intervention (pre-meal)
WP (–15min) WP (–30min) Casein Gluten
Mean 95% CI Mean 95% CI Mean 95% CI Mean 95% CI Timing (P)* Protein type (P)†
tAUC
NEFA, mmol/l×–15/–30 to 360min 138·1 128·1, 148·0 140·9 130·9, 150·8 130·5 120·6, 140·5 132·2 122·3, 142·2 0·7233 0·4792
iAUC
TAG, mmol/l×–15/–30 to 360min 250·2 197·6, 302·8 256·9 204·3, 309·4 243·8 191·2, 296·3 242·5 189·9, 295·0 0·8659 0·9740
Insulin, pmol/l×–15/–30 to 360min 43 539·8 33 753·6, 53 325·9 39 974 30 187·8, 49 760·2 38 511·9 28 398·0, 48 625·8 38 777·3 28 663, 48 891·2 0·6026 0·7296
Glucagon, pg/ml×–15/–30 to 360min 10 717·7 8155·4, 13 280·0 10 497·2 7987·6, 13 006·7 11 457·9 8718·7, 17 197·2 11 392·7 8669·0, 14 116·3 0·8839 0·9110
Glucose, mmol/l×–15/–30 to 360min 158·6 132·9, 184·4 156·6 125·3, 186·8 122·6 96·9, 148·3 133·3 107·6, 159·0 0·9036 0·1336
GLP-1, pmol/l×–15/–30 to 360min 4052·4 3163·0, 4941·9 4048·1 3158·7, 4937·6 4300·7 3411·3, 5190·1 4194·5 3305·1, 5083·9 0·9942 0·9263
GIP, pmol/l×–15/–30 to 360min 16 986·8 14 076·2, 19 897·4 17 759·9 14 849·3, 20 670·5 18 039·8 15 129·2, 20 950·4 15 404·4 12 493·8, 18 315·0 0·7274 0·4049
Paracetamol‡, µmol/l×–15/–30 to 360min 19 202·6 16 345·6, 22 059·5 22 771·7 19 383·7, 26 159·6 21 026·7 17 898·3, 24 155·0 21 031·6 17 902·5, 24 160·7 0·1896 0·6087
Leu, µg/mg×–15/–30 to 360min 57 173·8a 48 817·5, 65 530·0 – 46 660·3a 38 304·0, 55 016·6 33 787·8b 25 431·5, 42 144·1 – 0·0006
Ile, µg/mg×–15/–30 to 360min – – <0·0001
Median 38 350·9a 28 641·8b 20 752·8c
95% CI 22 768·7, 42 933·1 24 059·6, 33 224·0 16 170·6, 25 335·0
Val, µg/mg×–15/–30 to 360min 53 233·6a 45 119·4, 51 347·9 – 56 105·6a 47 991·3, 64 219·8 32 447·3b 24 333·0, 40 561·6 – 0·0002
Lys, µg/mg×–15/–30 to 360min – – 0·0411
Median 901·0a 960·5a 535·5b
95% CI 571·5, 1230·5 609·0, 1311·7 339·7, 731·3
Thr, µg/mg×–15/–30 to 360min 21 684·8a 19 019·8, 24 278·7 – 15 726·8b 13 132·8, 18 320·7 11 536·7c 8942·7, 14 130·6 – <0·0001
GLP-1, glucagon-like polypeptide 1; GIP, gastric inhibitory polypeptide.
a,b,c Values within a row with unlike superscript letters were significantly different (P<0·05).
* Student’s t test was applied for analysing differences on the postprandial responses.
† One-way ANOVA was applied for analysing differences on the postprandial responses. The hypothesis was to test whether iAUC or tAUC was significantly different between the three interventions WP (–15min), casein and gluten. The
hypothesis was to test whether iAUC or tAUC was significantly different between WP (–15min) and WP (–30min).
‡ For paracetamol, n 15.
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Insulin, glucagon and glucose
The insulin concentration increased after consumption of all
four pre-meals (Fig. 2(a)). WP (–15min), WP (–30min) and
casein induced maximum insulin concentrations after 15min,
whereas gluten reached maximum insulin concentration at time
point 30min. Insulin concentrations returned to normal fasting
ranges in all four groups after 360min. We observed a sig-
nificant effect of timing (P= 0·0001) and protein quality
(P= 0·0062) during the response period. The time course for
gluten was different from that of WP (P= 0·0008) and casein
(P= 0·008) due to the lower insulin concentrations at time
points 0 and 15min. The groups did not differ with regard to
iAUC.
Plasma glucagon increased in all four groups and reached a
maximum 15min after the main meal and returned to near
fasting values after 360min (Fig. 2(b)). Both timing (P< 0·0001)
and protein type (P< 0·0001) affected the glucagon secretion
pattern, but the iAUC were similar in the groups. The early
response to gluten was smaller than the early response to WP
(P< 0·0001) and casein (<0·0001). The glucose responses for
the four groups fluctuated between 5·1 and 6·3mmol/l during
the postprandial period at 0–120min (Fig. 2(c)). After 120min,
blood glucose was stable around 5·5mmol/l in all four groups.
We observed no effect of timing (P= 0·40) or protein quality
(P= 0·93), and AUC were similar.
Incretins (glucose-dependent insulinotropic peptide and
glucagon-like peptide 1)
GIP concentrations increased immediately after consumption of
the pre-meals and peaked after 120min (Fig. 3(a)) and had
returned to fasting levels in any of the groups even at 360min.
The protein type affected the progression curve for GIP
(P= 0·0103). Gluten was significantly different from WP
(P= 0·0298) and casein (P= 0·0036), due to a steeper rise in GIP
after milk-protein pre-meals. However, timing had no effect
(P= 0·08), and the iAUC did not differ significantly among the
interventions.
For GLP-1, the response profiles were similar in the four
groups (Fig. 3(b)). Maximum concentrations reached after
120min. Thus, neither timing nor protein type had an effect on
GLP-1.
S-paracetamol
The S-paracetamol concentration rose shortly after the main
meal in all four groups and reached maximum at 60min (Fig. 4).
Paracetamol was lower after WP (–15min) than after WP
(–30min) at 15min after the main meal (P= 0·028). At time
point 30min, the concentration of S-paracetamol was sig-
nificantly higher in the casein (P= 0·031) and gluten (P= 0·007)
group than in the WP group. Neither timing nor protein quality
had any effect on iAUC paracetamol.
Free amino acids
A total of twenty free AA were detectable in plasma after
ingestion of the four pre-meals, both at fasting (–15min) and at
time points 60 and 360min (Table 4 and online Supplementary
Table S1). WP was rich in BCAA, threonine and lysine (Table 1).
iAUC differed significantly between the three different protein
types regarding valine (P= 0·0002), leucine (P= 0·0006), iso-
leucine (P< 0·0001), lysine (P= 0·0411) and threonine
(P<0·0001) and was higher after WP than after gluten. Also,
iAUC for isoleucine and threonine were higher for WP than for
casein.
Discussion
In this study, we examined how PPL was affected by the time
between a pre-meal and a fat-rich test meal as well as by the
protein type of the pre-meal before a fat-rich meal.
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Fig. 1. Postprandial plasma responses of TAG (a) and NEFA (b) after ingestion of pre-meal of whey protein (WP), casein or gluten 15min prior, or WP 30min before a
fat-rich meal. Values are means (n 16), with their standard errors represented by vertical bars. Data were analysed using ANOVA for repeated measurement to
examine the effect of protein type on the postprandial responses. , WP (–15min); , WP (–30min); , casein; , gluten.
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Interestingly, we found that the timing and the protein quality of
the pre-meal had no effect on our primary outcome, that is,
TAG responses. In contrast, both the timing and the protein
type of the pre-meal (17·6 g pure protein) modified pancreatic
hormone secretion (insulin and glucagon) in subjects with the
MetS. Furthermore, we found that gastric emptying was more
delayed after a pre-meal with WP (–15min) than after a pre-
meal with casein, gluten or WP (–30min).
We expected to find a difference in TAG responses, since the
potent insulinotropic effect of a WP pre-meal could induce
larger reductions in TAG responses due to the stimulated
lipolytic activity of lipoprotein lipase(15). Previous studies show
that 45 g WP consumed as a part of a fat-rich meal reduces
postprandial TAG responses compared with other protein types
(casein, gluten and cod protein) in subjects with and without
T2D(15,16,20). In contrast, Mariotti et al.(21) showed that due to
physiochemical properties, 45 g casein induced a significantly
larger reduction in TAG than WP in overweight men. Interest-
ingly, we found no difference in either lipid responses or NEFA
suppression between the intervention groups. It is likely that
these discrepancies are caused by the difference in total protein
content. This might indicate that the effective WP threshold for
TAG suppression is somewhere between 20 and 45 g WP. We
here chose to use 17·6 g pure protein, because this is a realistic
maximum dose to consume as a pre-meal since 17·6 g pure
protein corresponds to 20 g WP, which we also used in a pre-
vious study(17). In the present study, we compared a 20 g WP
pre-meal to a pre-meal with no protein and therefore did not
include 0 g in the present study.
Acute human studies show that WP has a more potent
insulinotropic effect than other protein types(11–13). We con-
firmed these findings by showing that WP preferentially sti-
mulated insulin secretion. Insulin stimulation was also affected
by the timing, with consumption of WP 30min before the fat-
rich meal generating earlier insulin stimulation than consump-
tion of WP (–15min) before the meal. This was reflected in the
significantly higher insulin concentration at time point 0min
(just before consumption of the main meal) and may explain
the time-to-intervention interaction observed. We chose to
serve the pre-meal at time point –30 and –15 min, because these
are the time points at which diabetics treated with meal-time
insulin usually administered before a meal. A further advantage
of these time points is that they reflect preferred routines since
medicine adherence improves if the medicine is taken close to
meals. WP and casein amplified insulin secretion more than
gluten within the first 30min after consumption of a pre-meal.
We expected to observe a difference between WP and casein
due to their different solubility and hence faster absorption(22),
but this was not found. An explanation could be that larger
protein doses are needed to reveal differences in insulin
responses. However, a recent study showed that co-ingestion of
50 g WP or casein with maltodextrin caused no difference in
insulin response(23). It is well known that insulin and glucagon
are co-secreted in response to consumption of proteins and
single AA(24,25). In agreement with this, we observed that all
three protein types stimulated glucagon secretion and more so
for WP and casein than for gluten. The AA composition
demonstrated in plasma may explain this co-secretion and the
higher insulin and glucagon concentrations after the milk pro-
tein pre-meal. The iAUC for BCAA, lysine and threonine after
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Fig. 2. Postprandial plasma responses of insulin (a), glucagon (b) and
glucose (c) after ingestion of pre-meal of whey protein (WP), casein or gluten
15min prior, or WP 30min before a fat-rich meal. Values are means (n 16), with
their standard errors represented by vertical bars. Data were analysed using
ANOVA for repeated measurement to examine the effect of protein type on the
postprandial responses. Significant differences (P< 0·05): * WP (–15min) v.WP
(–30min),†WP v.gluten,‡ casein v.gluten, §WP v. casein. ,WP (–15min);
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the meal were significantly higher for WP and casein than for
gluten (Table 4 and online Supplementary Table S1). These five
AA play a key role in the insulinotropic response(14). In the
present study, the protein quality affected GIP; however, the
mechanism of action is currently unknown.
We did expect a suppression of blood glucose levels sec-
ondary to the insulin stimulation observed; however, glucose
responses were influenced neither by timing nor by protein
quality. This is in accordance with the previous studies report-
ing similar effects on blood glucose of WP and casein at doses
between 16·2 and 55 g when proteins are consumed before a
carbohydrate-rich meal or as part of the meal(7,20,23,26). How-
ever, we previously demonstrated that 45 g WP consumed as a
part of fat-rich meal lowered glucose iAUC more than casein,
gluten and cod protein(16). The discrepancy between the results
in the present study and our previous study(16) may at least
partially be related to the differences in the amounts of protein,
as the amount of protein affects the insulin response, or to the
differences in the fat composition of the meals. In the present
study, we included 70 g fat per meal to exceed the normal
lipoprotein capacity. Such a fat-rich test meal is obviously not
applicable to everyday life but is recognised as a suitable way of
studying PPL(16,27).
We used paracetamol as an indicator of the liquid phase
gastric emptying. Paracetamol was administered to the fat-rich
meals. It is likely that the large amount of fat (70 g fat) con-
tributes to a delay in gastric emptying and did so to the same
extent in the four pre-meal situations. The WP (–15min)
pre-meal delayed gastric emptying more compared with the WP
(–30min) pre-meal. Furthermore, the paracetamol concentra-
tions were lower 30min postprandially for WP compared with
casein and gluten, illustrating a delayed gastric emptying. This is
in agreement with previous studies demonstrating that a WP
pre-meal delays gastric emptying(10,17), but it is a new obser-
vation that the duration of the time gap between the pre-meal
and the main meal also affects gastric emptying. It is likely that
the AA level is higher before the meal when WP is given 30min
before the fat-rich mean compared with when it is given 15min
before. This may partly explain the difference in gastric emp-
tying. Thus, we previously found that the BCAA, isoleucine, was
higher after WP than after gluten and casein and that it was
associated with a delayed gastric emptying(28). Interestingly, Ma
et al.(29) recently showed that the ability to reduce postprandial
glycaemia and delay gastric emptying was maintained in T2D
subjects after intervention with 25 g WP as a pre-meal for
4 weeks.
One of the main strength of the present study was its ran-
domised, crossover study design where each participant served
as his or her own matched control. In addition, we used protein
types applied in daily life that were easy to eat.
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Fig. 3. Postprandial plasma responses of glucose-dependent insulinotropic peptide (GIP) (a) and glucagon-like peptide 1 (GLP-1) (b) after ingestion of pre-meal of
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Fig. 4. Postprandial plasma responses of paracetamol after ingestion of pre-
meal of whey protein (WP), casein or gluten 15min prior, or WP 30min before
a fat-rich meal. Values are means (n 15), with their standard errors
represented by vertical bars. Data were analysed using ANOVA for repeated
measurement to examine the effect of protein type on the postprandial
responses. Significant differences (P< 0·05): * WP (–15min) v. WP (–30min),
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In conclusion, intake of 17·6 g protein pre-meal did not alter
the lipid response (TAG and NEFA) to a fat-rich meal, and we
must therefore reject our hypothesis. However, we demon-
strated that hormone secretion (insulin and glucagon) depends
on both pre-meal timing and protein quality. A WP pre-meal
consumed 30min before a meal stimulated hormone responses
earlier than WP consumed 15min before a meal. WP and casein
displayed more potent insulinotropic actions compared with
gluten protein. Finally, our results support that a WP pre-meal
consumed 15min before the fat-rich meal delays gastric emp-
tying more than a WP pre-meal consumed 30min before
the meal.
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